Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IBB vs FBT overlap: 30% of top holdings shared

Bottom line

How much do IBB and FBT overlap?

30% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 37.8% of IBB's assets and 40.6% of FBT's. They share a meaningful core but differ in the rest of the portfolio.

IBB holds far more positions (254 vs 32), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

IBBFBT
Weight overlap (top 25)30%
Shared holdings13
Weight in shared holdings37.8%40.6%
Total positions25432
Expense ratio0.44%0.55%
Holdings as ofSep 30, 2025Jun 30, 2026

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jun 30, 2026)

Holdings IBB and FBT have in common

Holding% of IBB% of FBTOverlap
Vertex Pharmaceuticals, Inc.7.66%3.07%3.07%
Amgen, Inc.7.50%2.78%2.78%
Alnylam Pharmaceuticals, Inc.5.68%2.52%2.52%
Argenx SE3.15%3.13%3.13%
Natera, Inc.2.11%3.79%2.11%
Biogen, Inc.2.03%3.37%2.03%
United Therapeutics Corp.1.82%2.56%1.82%
Incyte Corp.1.62%3.18%1.62%
Illumina, Inc.1.41%3.92%1.41%
Genmab A/S1.38%2.62%1.38%
Neurocrine Biosciences, Inc.1.34%3.53%1.34%
Exelixis, Inc.1.07%3.32%1.07%
BioMarin Pharmaceutical, Inc.1.02%2.83%1.02%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IBB

  1. BlackRock Funds III — 13.18%
  2. Gilead Sciences, Inc. — 7.52%
  3. Regeneron Pharmaceuticals, Inc. — 5.70%
  4. IQVIA Holdings, Inc. — 3.18%
  5. Insmed, Inc. — 2.95%
  6. Mettler-Toledo International, Inc. — 2.49%
  7. BeOne Medicines Ltd. — 2.11%
  8. Waters Corp. — 1.77%
  9. Medpace Holdings, Inc. — 1.16%
  10. Ionis Pharmaceuticals, Inc. — 1.03%
  11. Madrigal Pharmaceuticals, Inc. — 0.92%
  12. Moderna, Inc. — 0.88%

Only in FBT

  1. Corcept Therapeutics Inc — 5.60%
  2. Neogenomics Inc — 5.12%
  3. Veracyte Inc — 5.10%
  4. Bruker Corp — 4.32%
  5. Alkermes Plc — 4.24%
  6. Krystal Biotech Inc — 3.87%
  7. Axsome Therapeutics Inc — 3.71%
  8. Bio-techne Corp — 3.43%
  9. Arrowhead Pharmaceuticals Inc — 3.38%
  10. Halozyme Therapeutics Inc — 3.11%
  11. Repligen Corp — 3.07%
  12. Biontech Se — 2.63%

Asset mix

Asset typeIBBFBT
Stocks99.8%100.0%
Cash & short-term funds13.4%0.1%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jun 30, 2026)

Country mix

CountryIBBFBT
US98.6%85.0%
NL4.3%3.1%
IE0.5%4.2%
CH2.7%2.5%
DE0.7%2.6%
DK2.2%2.6%
GB1.0%—
KY0.9%—

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jun 30, 2026)

Check another pair

FAQ

How much do IBB and FBT overlap?
About 30% by weight. 13 securities appear in both funds' top 25 holdings; they make up 37.8% of IBB's assets and 40.6% of FBT's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IBB and FBT have in common?
The largest shared holdings are Argenx SE, Vertex Pharmaceuticals, Inc., Amgen, Inc., Alnylam Pharmaceuticals, Inc., Natera, Inc..
Should I own both IBB and FBT?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IBB or FBT?
IBB is broader, with 254 positions versus 32 for FBT. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.